Document ID: chunk:federal_register_of_legislation:F2025C00158:clause:4_1:p50
Version: federal_register_of_legislation:F2025C00158
Segment Type: clause
Provision Reference: sch 4 cl 1 (pt 50/191)
Character Range: 10044464–10058102

but need not delay treatment.
C5959               P5959          CN5959           Aciclovir                                                                                                                                                                  Herpes zoster ophthalmicus                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Compliance with Authority Required procedures - Streamlined Authority Code 5959

C5960               P5960          CN5960           Valaciclovir                                                                                                                                                               Initial moderate to severe genital herpes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Compliance with Authority Required procedures - Streamlined Authority Code 5960
                                                                                                                                                                                                                               Microbiological confirmation of diagnosis [viral culture, antigen detection or nucleic acid amplification by polymerase chain reaction (PCR)] is desirable but need not delay treatment.
C5961               P5961          CN5961           Valaciclovir                                                                                                                                                               Recurrent moderate to severe genital herpes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Compliance with Authority Required procedures - Streamlined Authority Code 5961
                                                                                                                                                                                                                               Episodic treatment
                                                                                                                                                                                                                               Microbiological confirmation of diagnosis [viral culture, antigen detection or nucleic acid amplification by polymerase chain reaction (PCR)] is desirable but need not delay treatment.
C5962               P5962          CN5962           Valaciclovir                                                                                                                                                               Herpes zoster                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Compliance with Authority Required procedures - Streamlined Authority Code 5962
                                                                                                                                                                                                                               The treatment must be administered within 72 hours of the onset of the rash.
C5964               P5964          CN5964           Aciclovir                                                                                                                                                                  Herpes simplex keratitis

C5965               P5965          CN5965           Aciclovir                                                                                                                                                                  Herpes simplex keratitis

C5967               P5967          CN5967           Aciclovir                                                                                                                                                                  Herpes zoster                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Compliance with Authority Required procedures - Streamlined Authority Code 5967
                                                                                                                                                                                                                               The treatment must be administered within 72 hours of the onset of the rash.
C5968               P5968          CN5968           Valaciclovir                                                                                                                                                               Herpes zoster ophthalmicus                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Compliance with Authority Required procedures - Streamlined Authority Code 5968

C5969               P5969          CN5969           Sofosbuvir with velpatasvir                                                                                                                                                Chronic hepatitis C infection                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Compliance with Authority Required procedures
                                                                                                                                                                                                                               Patient must meet the criteria set out in the General Statement for Drugs for the Treatment of Hepatitis C; AND
                                                                                                                                                                                                                               Patient must be taking this drug as part of a regimen set out in the matrix in the General Statement for Drugs for the Treatment of Hepatitis C, based on the hepatitis C virus genotype, patient treatment history and cirrhotic status; AND
                                                                                                                                                                                                                               The treatment must be limited to a maximum duration of 12 weeks.
C5970               P5970          CN5970           Amino acid formula with fat, carbohydrate without phenylalanine                                                                                                            Phenylketonuria

                                                    Amino acid formula with fat, carbohydrate, vitamins, minerals and trace elements without phenylalanine

                                                    Protein formula with amino acids, carbohydrates, vitamins and minerals without phenylalanine, and supplemented with docosahexaenoic acid

C5971               P5971          CN5971           Famciclovir                                                                                                                                                                Recurrent moderate to severe genital herpes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Compliance with Authority Required procedures - Streamlined Authority Code 5971
                                                                                                                                                                                                                               Suppressive therapy
                                                                                                                                                                                                                               Microbiological confirmation of diagnosis [viral culture, antigen detection or nucleic acid amplification by polymerase chain reaction (PCR)] is desirable but need not delay treatment.
C5973               P5973          CN5973           Folinic acid                                                                                                                                                               Megaloblastic anaemias
                                                                                                                                                                                                                               The condition must be a result of folic acid deficiency from the use of folic acid antagonists.
C5974               P5974          CN5974           Amino acid formula with fat, carbohydrate, vitamins, minerals, trace elements and medium chain triglycerides                                                               Eosinophilic oesophagitis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Compliance with Authority Required procedures
                                                                                                                                                                                                                               Continuing treatment
                                                    Amino acid synthetic formula supplemented with long chain polyunsaturated fatty acids and medium chain triglycerides                                                       Must be treated by a clinical